AKT1 and cancer: In a large number of cancer cell lines, it has been shown to decrease FOXO3a phosphorylation through Akt inhibition, leading to FOXO3a translocation to the nucleus where it can “switch on” the expression of genes, such as p27, FasL, and BIM by inducing cell-cycle arrest and promoting apoptosis [74].